JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CBL
4826
DELISTED
CBL& Associates Properties, Inc.
CBL
| $14K | ﹤0.01% |
69,967
-12,025
| -15% | -$8.18K |
2013 Q2
27 quarters
|
|
|
GNC
4827
DELISTED
GNC Holdings, Inc.
GNC
| $14K | ﹤0.01% |
30,912
-1,180
| -4% | -$2.07K |
2013 Q2
27 quarters
|
|
|
RRTS
4828
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $14K | ﹤0.01% |
5,333
+3,068
| +135% | +$22.5K |
2019 Q2
3 quarters
|
|
|
CO
4829
DELISTED
Global Cord Blood Corporation
CO
| $14K | ﹤0.01% |
+4,543
| New | +$19.9K |
2020 Q1
0 quarters
|
|
4830
Bridgford Foods
BRID
| $13K | ﹤0.01% |
555
-1,709
| -75% | -$36K |
2019 Q1
4 quarters
|
|
|
DBVT
4831
DBV Technologies S.A. American Depositary Shares
DBVT
$663M
| $13K | ﹤0.01% |
+328
| New | +$29.4K |
2020 Q1
0 quarters
|
|
4832
Invesco Value Municipal Income Trust
IIM
$514M
| $13K | ﹤0.01% |
923
+202
| +28% | +$3.06K |
2019 Q1
4 quarters
|
|
|
NCSM
4833
DELISTED
NCS Multistage Holdings
NCSM
| $13K | ﹤0.01% |
1,028
+155
| +18% | +$4.34K |
2017 Q3
10 quarters
|
|
4834
Quantum Corp
QMCO
$1.36B
| $13K | ﹤0.01% |
+220
| New | +$19.8K |
2020 Q1
0 quarters
|
|
|
APTO
4835
DELISTED
Aptose Biosciences, Inc.
APTO
| $13K | ﹤0.01% |
5
-79
| -94% | -$236K |
2019 Q3
2 quarters
|
|
|
SIOX
4836
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $13K | ﹤0.01% |
5,409
+4,695
| +658% | +$16.9K |
2019 Q4
1 quarter
|
|
|
ELGX
4837
DELISTED
Endologix Inc
ELGX
| $13K | ﹤0.01% |
18,168
-36,044
| -66% | -$44.1K |
2015 Q4
17 quarters
|
|
|
EQC.PRD
4838
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $13K | ﹤0.01% |
+500
| New | +$14K |
2020 Q1
0 quarters
|
|
4839
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.8B
| $12K | ﹤0.01% |
+135
| New | +$12.4K |
2020 Q1
0 quarters
|
|
|
CKPT
4840
DELISTED
Checkpoint Therapeutics
CKPT
| $12K | ﹤0.01% |
783
-4,673
| -86% | -$82.7K |
2019 Q2
3 quarters
|
|
4841
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.16B
| $12K | ﹤0.01% |
+475
| New | +$12.1K |
2020 Q1
0 quarters
|
|
4842
Mizuho Financial
MFG
$132B
| $12K | ﹤0.01% |
5,318
+1,018
| +24% | +$2.78K |
2013 Q2
27 quarters
|
|
4843
Medallion Financial
MFIN
$273M
| $12K | ﹤0.01% |
6,617
-159
| -2% | -$884 |
2019 Q1
4 quarters
|
|
4844
Banco Santander
SAN
$194B
| $12K | ﹤0.01% |
5,232
-1,304,684
| -100% | -$4.47M |
2013 Q2
27 quarters
|
|
|
NTGN
4845
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $12K | ﹤0.01% |
4,535
-109
| -2% | -$179 |
2018 Q2
7 quarters
|
|
4846
Direxion Daily Real Estate Bull 3X ETF
DRN
$34.5M
| $11K | ﹤0.01% |
1,300
+1,140
| +713% | +$28.9K |
2019 Q4
1 quarter
|
|
4847
Fidelity MSCI Industrials Index ETF
FIDU
$2.21B
| $11K | ﹤0.01% |
360
| – | – |
2019 Q3
2 quarters
|
|
4848
First Trust Financials AlphaDEX Fund
FXO
$1.03B
| $11K | ﹤0.01% |
502
-63,656
| -99% | -$1.9M |
2013 Q2
27 quarters
|
|
4849
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$571M
| $11K | ﹤0.01% |
+300
| New | +$13.2K |
2020 Q1
0 quarters
|
|
4850
FreightCar America
RAIL
$226M
| $11K | ﹤0.01% |
11,803
-4,652
| -28% | -$6.96K |
2015 Q4
17 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.